Literature DB >> 15554235

Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.

Dharamainder Choudhary1, Ingela Jansson, Mansoor Sarfarazi, John B Schenkman.   

Abstract

While much is known about inducibility of the xenobiotic-metabolizing forms of cytochrome P450, the Family 1-3 enzymes, less well understood is the purpose for the presence of some of these forms in the developing conceptus. Many cytochrome P450 forms are present in the embryo and fetus, like the anabolic forms in Families 5 and higher, and are known to produce molecules with specific functions, e.g., cholesterol, steroids, and their metabolites necessary for normal physiological functions. As we gain greater understanding of the cell cycle and its regulation, and the roles of nuclear receptors in modulating transcriptional activities, a picture begins to emerge in which cytochrome P450 forms appear as molecule-altering enzymes producing and eliminating ligands associated with nuclear receptor activities. For these CYP enzymes to exert a developmental action, a controlled spatial and temporal expression pattern would be essential. Studies now indicate the existence of such temporal control on the appearance of a number of these enzymes and the necessary coenzyme, NADPH-cytochrome P450 reductase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554235     DOI: 10.1081/dmr-200033447

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  6 in total

1.  RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development.

Authors:  Lai Peng; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

2.  The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.

Authors:  Rui Zhu; Jennifer J Kiser; Heiner I Seifart; Cedric J Werely; Charles D Mitchell; David Z D'Argenio; Courtney V Fletcher
Journal:  J Clin Pharmacol       Date:  2011-05-10       Impact factor: 3.126

3.  Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.

Authors:  Erin P Madeen; Christiane V Löhr; Hannah You; Lisbeth K Siddens; Sharon K Krueger; Roderick H Dashwood; Frank J Gonzalez; William M Baird; Emily Ho; Lisa Bramer; Katrina M Waters; David E Williams
Journal:  Mol Carcinog       Date:  2016-03-17       Impact factor: 4.784

4.  Dexamethasone suppresses the expression of multiple rat carboxylesterases through transcriptional repression: evidence for an involvement of the glucocorticoid receptor.

Authors:  Deshi Shi; Jian Yang; Dongfang Yang; Bingfang Yan
Journal:  Toxicology       Date:  2008-09-30       Impact factor: 4.221

5.  Basal and 3,3',4,4',5-pentachlorobiphenyl-induced expression of cytochrome P450 1A, 1B and 1C genes in zebrafish.

Authors:  Maria E Jönsson; Rodrigo Orrego; Bruce R Woodin; Jared V Goldstone; John J Stegeman
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-12       Impact factor: 4.219

6.  Genes Expressed During Fruiting Body Formation of Agrocybe cylindracea.

Authors:  Sung Mi Shim; Sang Beom Kim; Hey Young Kim; Hyun-Su Rho; Hyun Sook Lee; Min Woong Lee; U Youn Lee; Kyung Hoan Im; Tae Soo Lee
Journal:  Mycobiology       Date:  2006-12-31       Impact factor: 1.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.